SR ONE CAPITAL MANAGEMENT, LLC

13D and 13G Filings

13D/G filings
13D on 7 securities
CIK
0001853723
All SEC filings
View on sec.gov
Issuer % of Class Filed
ADARx Pharmaceuticals, Inc. 13D
ADRX · 00654F105
9.3% 10/5/2026
Event 9/28/2026
Zenas BioPharma, Inc. 13D/A Amendment 2
ZBIO · 98937L105
7.7% 8/17/2026
Event 8/13/2026
Veradermics, Inc. 13D/A Amendment 1
MANE · 922967104
4.9% 8/14/2026
Event 8/12/2026
Odyssey Therapeutics, Inc. 13D
ODTX · 67613T104
8.0% 5/18/2026
Event 5/11/2026
Avalyn Pharma Inc. 13D
AVLN · 05348Y105
7.5% 5/8/2026
Event 5/1/2026
Veradermics, Inc. 13D
MANE · 922967104
6.4% 2/11/2026
Event 2/5/2026
KALA BIO, Inc. 13D/A Amendment 2
KALA · 483119202
4.6% 10/15/2025
Event 10/14/2025
Zenas BioPharma, Inc. 13D/A Amendment 1
ZBIO · 98937L105
9.4% 10/14/2025
Event 10/9/2025
KALA BIO, Inc. 13D/A Amendment 1
KALA · 483119202
5.5% 10/1/2025
Event 9/29/2025
ORIC Pharmaceuticals, Inc. 13D/A Amendment 1
ORIC · 68622P109
4.8% 8/14/2025
Event 8/12/2025
ORIC Pharmaceuticals, Inc. 13D
ORIC · 68622P109
5.4% 6/5/2025
Event 5/29/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.